Myeloma Immunotherapy Trials Paused – Curetoday.com
Curetoday.com |
Myeloma Immunotherapy Trials Paused
Curetoday.com Myeloma Immunotherapy Trials Paused. Merck will be pausing two trials testing Keytruda in patients with multiple myeloma. JASON HARRIS. PUBLISHED: JUNE 13, 2017. Be the first to discuss this article on CURE’s forum. >> Talk about this article with … |
|
Stem cells might not be a good option for your kid’s sports injury
Miami Herald Over the last several years, we have seen a dramatic increase in interest in regenerative medicine, especially the use of PRP and mesenchymal stem cells to help athletes return to their sport after injury. Yet many patients and caregivers struggle to … |
|
Stem cells might not be a good option for your kid’s sports injury
Miami Herald Over the last several years, we have seen a dramatic increase in interest in regenerative medicine, especially the use of PRP and mesenchymal stem cells to help athletes return to their sport after injury. Yet many patients and caregivers struggle to … |
|
Stem cell research could help the infertile
Shanghai Daily (subscription) SCIENTISTS at Beijing’s Tsinghua University are leading the world in inducing in-vitro differentiation of human embryonic stem cells into follicle-like cells. The breakthrough is expected to help the study of premature ovarian failure and improve … |
|
Stem cell research could help the infertile
Shanghai Daily (subscription) SCIENTISTS at Beijing’s Tsinghua University are leading the world in inducing in-vitro differentiation of human embryonic stem cells into follicle-like cells. The breakthrough is expected to help the study of premature ovarian failure and improve … |
|
Stem cell research could help the infertile
Shanghai Daily (subscription) SCIENTISTS at Beijing’s Tsinghua University are leading the world in inducing in-vitro differentiation of human embryonic stem cells into follicle-like cells. The breakthrough is expected to help the study of premature ovarian failure and improve … |
WRAL Tech Wire |
New frontier in cancer care: Turning blood into living drugs :: Editor’s …
WRAL Tech Wire Immune therapy is the hottest trend in cancer care and this is its next frontier — creating “living drugs” that grow inside the body into an army that seeks and … |